ClinicalTrials.Veeva

Find clinical trials for Asthma in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Chronic Obstructive Pulmonary Disease
Allergic Rhinitis
Obstructive Lung Diseases
Rhinitis
Lung Diseases
Respiration Disorders

Asthma trials near Warszawa, Mazowieckie, POL:

Multicentre Post-market Study of Ectoin® Inhalation Solution in Treatment of Asthma. (EIL-AST)

evidence for supportive treatment and symptoms alleviation in asthma by evaluating the clinical efficacy of Ectoin® Inhalation Solution in p....

Active, not recruiting
Asthma
Device: Ectoin® Inhalation Solution
Bitop
Bitop

Warszawa, Poland and 4 other locations

This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Placebo
Drug: Dexpramipexole Dihydrochloride

Phase 3

Areteia Therapeutics

Piaseczno, Poland and 125 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Enrolling
Asthma Attack
Asthma; Eosinophilic
Drug: Placebo
Drug: Dexpramipexole Dihydrochloride

Phase 3

Areteia Therapeutics

Piaseczno, Poland and 117 other locations

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Enrolling
Moderate to Severe Asthma
Drug: povorcitinib
Other: placebo

Phase 2

Incyte
Incyte

Warszawa, Poland and 94 other locations

and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...

Enrolling
Asthma
Drug: Placebo
Drug: Atuliflapon

Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 350 other locations

variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...

Enrolling
Asthma
Drug: BFF pMDI 320/9 μg
Drug: BFF MDI 320/9.6 μg

Phase 3

AstraZeneca
AstraZeneca

Piaseczno, Poland and 476 other locations

omalizumabTo evaluate the effect of dupilumab on asthma control at Week 24 compared to omalizumabTo evaluate the safety of dupilumab and om...

Enrolling
Asthma
Chronic Rhinosinusitis With Nasal Polyps
Drug: Omalizumab
Drug: Placebo

Phase 4

Sanofi
Sanofi

Warszawa, Mazowieckie, Poland and 92 other locations

A research study of how house dust mite tablets work compared to placebo in children aged between 5 and 11 years and who have allergy to house dust m...

Active, not recruiting
Allergic Rhinitis Due to House Dust Mite
Allergic Rhinitis Due to Dermatophagoides Pteronyssinus
Other: Placebo
Biological: Sublingual allergy immunotherapy tablet

Phase 3

ALK-Abelló

Warszawa, Poland and 116 other locations

This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.

Active, not recruiting
Nasal Polyps
Biological: Depemokimab (GSK3511294)
Drug: Placebo

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Nadarzyn, Poland and 84 other locations

This is a randomized, double-blind, placebo-controlled, parallel-group, international, multicenter, Phase 3 study to evaluate the efficacy and safety...

Active, not recruiting
Nasal Polyposis
Biological: Benralizumab 30 mg
Biological: Matched placebo

Phase 3

AstraZeneca
AstraZeneca

Nadarzyn, Poland and 115 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems